In contrast to breast cancer where a KLF6 splice variant promotes metastatic progression47, our results suggest that full-length KLF6, downstream of a robust super enhancer, promotes ccRCC growth in vitro and in vivo. Here, KLF6 is linked to breast carcinoma.